15 April 2021 - Europe has hinted it will not renew contracts for coronavirus vaccines produced by pharmaceutical giants AstraZeneca ...
14 April 2021 - Approval based on Phase 3 CheckMate-9ER trial results showing Opdivo in combination with Cabometyx significantly improved overall ...
15 April 2021 - Consultation on the content of the draft Cost Recovery Implementation Statement for listing medicines on the ...
12 April 2021 - Patient and public involvement and engagement have become increasingly embedded in health technology assessment over the last ...
13 April 2021 - Our plan is based on three key pillars: ending the pandemic and building a more resilient system, ...
15 April 2021 - Australia’s vaccine rollout has been dealt another blow as Novavax confirms manufacturing supply shortages mean it ...
14 April 2021 - Australia's sluggish vaccine rollout was last week thrown another curve ball, with new medical advice recommending ...
14 April 2021 - Parents of paediatric patients with haemophilia A are demanding the regulator to change the criteria for ...
14 April 2021 - Telix is pleased to announce that the TGA has accepted the Company’s submission for the registration ...
14 April 2021 - EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination ...
14 April 2021 - As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots ...
14 April 2021 - Moleculin Biotech announced today that the U.S. FDA has granted rare paediatric disease designation to its ...
14 April 2021 - The TGA has granted a provisional determination to GSK in relation to the monoclonal antibody treatment, ...
14 April 2021 - Approval based on unprecedented results from the ADAURA Phase III trial where Tagrisso reduced the risk ...
14 April 2021 - PHARMAC is making it easier for clinicians to access six treatments for rare metabolic disorders for ...